Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q3 2018 · 10-Q
Revenue$7.66B$7.66B+12.1% vs Q3 2017 Net Income$563.00M$563.00M−6.6% vs Q3 2017 EPS Diluted$0.32$0.32−5.9% vs Q3 2017 Gross Profit$3,946,000,000+14.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,183,000,000+8.9% Free Cash Flowderived$1,829,000,000+5.0% Margins · derivedGross margin51.5%+1.0 pt vs Q3 2017
Operating margin13.0%+1.7 pt vs Q3 2017
Net margin7.4%−1.5 pt vs Q3 2017
ended Sep 30, 2018 · filed Oct 31, 2018 · 31 d after period end